These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33348546)

  • 1. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.
    Cao Z; Weygant N; Chandrakesan P; Houchen CW; Peng J; Qu D
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
    Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
    Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DCLK1 and tuft cells: Immune-related functions and implications for cancer immunotherapy.
    Ding L; Weygant N; Ding C; Lai Y; Li H
    Crit Rev Oncol Hematol; 2023 Nov; 191():104118. PubMed ID: 37660932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles.
    Lazer LM; Kesavan Y; Gor R; Ramachandran I; Pathak S; Narayan S; Anbalagan M; Ramalingam S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112612. PubMed ID: 35738074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers.
    Ye L; Liu B; Huang J; Zhao X; Wang Y; Xu Y; Wang S
    Life Sci; 2024 Jan; 336():122294. PubMed ID: 38007147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments.
    Wu X; Qu D; Weygant N; Peng J; Houchen CW
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31979136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.
    Li L; Bellows CF
    Chin J Cancer Res; 2013 Apr; 25(2):134-42. PubMed ID: 23592893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells.
    Chandrakesan P; Panneerselvam J; Qu D; Weygant N; May R; Bronze MS; Houchen CW
    J Carcinog Mutagen; 2016 Apr; 7(2):. PubMed ID: 27335684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity.
    Ding L; Yang Y; Ge Y; Lu Q; Yan Z; Chen X; Du J; Hafizi S; Xu X; Yao J; Liu J; Cao Z; Weygant N
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of DCLK1 in cancer and cancer stem cells.
    Chhetri D; Vengadassalapathy S; Venkadassalapathy S; Balachandran V; Umapathy VR; Veeraraghavan VP; Jayaraman S; Patil S; Iyaswamy A; Palaniyandi K; Gnanasampanthapandian D
    Front Mol Biosci; 2022; 9():965730. PubMed ID: 36250024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage tracing and targeting of IL17RB
    Goto N; Fukuda A; Yamaga Y; Yoshikawa T; Maruno T; Maekawa H; Inamoto S; Kawada K; Sakai Y; Miyoshi H; Taketo MM; Chiba T; Seno H
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12996-13005. PubMed ID: 31182574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
    Zhang Y; Zoltan M; Riquelme E; Xu H; Sahin I; Castro-Pando S; Montiel MF; Chang K; Jiang Z; Ling J; Gupta S; Horne W; Pruski M; Wang H; Sun SC; Lozano G; Chiao P; Maitra A; Leach SD; Kolls JK; Vilar E; Wang TC; Bailey JM; McAllister F
    Gastroenterology; 2018 Jul; 155(1):210-223.e3. PubMed ID: 29604293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-137 Regulates the Tumorigenicity of Colon Cancer Stem Cells through the Inhibition of DCLK1.
    Sakaguchi M; Hisamori S; Oshima N; Sato F; Shimono Y; Sakai Y
    Mol Cancer Res; 2016 Apr; 14(4):354-62. PubMed ID: 26747706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional implication of Dclk1 and Dclk1-expressing cells in cancer.
    Westphalen CB; Quante M; Wang TC
    Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma.
    Ge Y; Liu H; Zhang Y; Liu J; Yan R; Xiao Z; Fan X; Huang X; An G
    Transl Oncol; 2022 Mar; 17():101317. PubMed ID: 34998236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell marker DCLK1 reprograms small extracellular vesicles toward migratory phenotype in gastric cancer cells.
    Carli ALE; Afshar-Sterle S; Rai A; Fang H; O'Keefe R; Tse J; Ferguson FM; Gray NS; Ernst M; Greening DW; Buchert M
    Proteomics; 2021 Jul; 21(13-14):e2000098. PubMed ID: 33991177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
    Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
    Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.